Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year, study finds

News release: Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year, study finds – Johns Hopkins Bloomberg School of Public Health

Original study: Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program – JAMA Network Open

Commentary on Twitter

Economic evaluation finds prescribers & patients motivated 30% of branded drug dispensing in Medicare Part D, an incremental annual cost of $1.7 billion Medicare & $270 million to patients vs switching to generics. @dr_msocal @GeBaiDC @JohnsHopkinsSPH https://t.co/MkVJdzLczG

— JAMA Network Open (@JAMANetworkOpen) March 3, 2021